Loading...
Please wait, while we are loading the content...
Similar Documents
Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies
| Content Provider | Scilit |
|---|---|
| Author | Haase, Volker H. |
| Copyright Year | 2017 |
| Description | Journal: Experimental cell research The oxygen-sensitive hypoxia-inducible factor (HIF) pathway plays a central role in the control of erythropoiesis and iron metabolism. The discovery of prolyl hydroxylase domain (PHD) proteins as key regulators of HIF activity has led to the development of inhibitory compounds that are now in phase 3 clinical development for the treatment of renal anemia, a condition that is commonly found in patients with advanced chronic kidney disease. This review provides a concise overview of clinical effects associated with pharmacologic PHD inhibition and was written in memory of Professor Lorenz Poellinger. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507591/pdf |
| Ending Page | 165 |
| Page Count | 6 |
| Starting Page | 160 |
| ISSN | 00144827 |
| e-ISSN | 10902422 |
| DOI | 10.1016/j.yexcr.2017.05.004 |
| Journal | Experimental cell research |
| Issue Number | 2 |
| Volume Number | 356 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2017-07-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Experimental cell research Urology and Nephrology Chronic Kidney Disease Clinical Trials Hypoxia-inducible Factor Prolyl Hydroxylase Domain |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cell Biology |